o Fund raising of €5.5 million through the issue of 83,924,897 new shares
o Sanyou (HK) International Medical Holding Co., limited strengthens its participation and holds 74.56% of the capital and voting rights of the Company
Bordeaux, Boston, February 2, 2024 – 6:00 p.m. CET – IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible) (the “Company”) medical technology company specializing in spinal implants announces the success of the capital increase in cash with maintenance of shareholders’ preferential subscription rights (“DSS”) announced on January 4, 2024 (the “Capital Increase”). This operation made it possible to raise an amount of €5.5 million through the issue of 83,924,897 new shares (“New Shares”) at a unit price of €0.0655 corresponding to the closing price of January 3, 2024 (0. 0655 €), preceding the setting of the price of the issue by the Board of Directors of Implanet.
If you wish to receive all of the company’s financial communications in real time, you can register directly by email to the following address: [email protected]